
Trials Discussed:STAREE (NCT02099123)REACT (NCT06692127)AMUNDSEN (NCT04951856)ENRICH-AF (NCT03950076)LIBREXIA-ACS (NCT05754957)PREMIUM (NCT05709626)SWITCH SWEDEHEART (NCT05183178) EMAIL-HF (NCT05890131)ADHERE-ASCVD (NCT07522645)TIME-HF (CTRI/2021/11/037797)H-HeFT & Met-HeFT (DANHEART, NCT03514108)ACASA-TAVI (NCT05035277)
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

S1 Ep37: ESC 2026 Hot Line Recap: 3 Trials Every Pharmacist Needs

36: 2026 ACC Consensus Pathway Redefines HFpEF Diagnosis, Treatment Priorities

35: Deprescribing in Cardiovascular Disease: A New AHA Roadmap for Tackling Polypharmacy

34: Putting the 2026 CKM Guidelines Into Practice: A Pharmacist's Perspective
Free AI-powered recaps of The Tell-Tale Heart: The Pharmacist's Cardiovascular Digest and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.